Hongchuan L. Jiang
Beijing, 100053, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Virtual histology imaging of lymph nodes via dynamic full-field optical coherence tomography and deep learning to differentiate metastasis.
Journal: Cancer biology & medicine
Published: March 30, 2026
Efbemalenograstim Alfa, an Fc Fusion Protein, Long‑Acting Granulocyte Colony-Stimulating Factor for Reducing the Risk of Chemotherapy-Induced Neutropenia: Results of a Phase II Randomized, Multicenter, Open‑Label Trial.
Journal: Clinical drug investigation
Published: December 24, 2024
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study.
Journal: iScience
Published: November 03, 2024
A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012).
Journal: Frontiers in oncology
Published: December 26, 2023
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?
Journal: Breast (Edinburgh, Scotland)
Published: November 09, 2023
Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.
Journal: NPJ breast cancer
Published: July 24, 2023
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy.
Journal: Journal of cancer research and clinical oncology
Published: March 14, 2023
Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study.
Journal: Chinese medical journal
Published: February 16, 2023
Axillary Downstaging and the Impact of Clinical Axillary Status on Efficacy of Neoadjuvant Therapy for HER2-Positive Breast Cancer: A Network Meta-Analysis.
Journal: Technology in cancer research & treatment
Published: January 20, 2023
Deep learning for real-time detection of breast cancer presenting pathological nipple discharge by ductoscopy.
Journal: Frontiers in oncology
Published: November 20, 2022
A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx ® in advanced breast cancer.
Journal: Frontiers in oncology
Published: October 14, 2022
Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.
Journal: NPJ breast cancer
Published: August 11, 2022
Last Updated: 09/26/2026